News
#BharatBiotech Submitted Data from Clinical Trials in the 2-18 Years Age Group for ... - Latest Tweet by DD News
The latest Tweet by DD News states, '#BharatBiotech submitted data from clinical trials in the 2-18 years age group for #COVAXIN to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and have provided their positive recommendations'
#BharatBiotech submitted data from clinical trials in the 2-18 years age group for #COVAXIN (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and have provided their positive recommendations pic.twitter.com/eqdTWgcJS9— DD News (@DDNewslive) October 12, 2021
(The above story first appeared on LatestLY on Oct 12, 2021 03:54 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
